Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02050321
Title A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Arizona
Indications

melanoma

Therapies

Acitretin + Vemurafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field